Data Characteristics
Attenuated inactivated vaccine clinical trial pre-screening data primarily originates from global clinical trial registries (e.g., ClinicalTrials.gov, WHO ICTRP), regulatory agency databases (e.g., FDA, EMA), and professional academic journals and conference materials. Data update frequencies vary; registries typically update monthly or quarterly, while academic materials are continuously published. Document structures include structured data tables (trial design, subject characteristics, primary/secondary endpoints, adverse event reports) and unstructured text (study protocols, informed consent forms, ethics approvals, investigator brochures). Specific fields include a large number of biomedical terms, disease codes (e.g., ICD-10), drug codes (e.g., ATC), and fields with specific units such as dosage, treatment duration, and immunogenicity indicators (e.g., antibody titers).
Constraints on Workflow Orchestration
The multi-source nature, varying update frequencies, and heterogeneity of attenuated inactivated vaccine clinical trial data require workflows with robust data integration and cleaning capabilities. Key information within unstructured text (e.g., exclusion criteria for specific genotype subjects, vaccine strain characteristics) requires advanced natural language processing techniques for extraction and structuring. The presence of biomedical terms and codes makes knowledge base matching and entity recognition critical workflow steps, necessitating pre-loaded or dynamically loaded specialized medical dictionaries. The extraction and standardization of fields with units, such as dosage, treatment duration, and antibody titers, demand higher robustness from data parsing modules. Furthermore, the complexity of trial protocols, such as multi-center, multi-arm designs, requires workflows to handle nested logic and conditional branching to ensure accurate pre-screening logic.
Configuration Settings
| Configuration Item | Recommended Value | Rationale |
|---|---|---|
maxContext | 4000 tokens | Attenuated inactivated vaccine clinical trial protocol documents are often lengthy. A sufficient context window is needed to accommodate key information and prevent the omission of pre-screening conditions due to truncation. |
Chunk size (Segment Length) | 800–1200 characters | Considering the coherence of biomedical text and the density of specialized terminology, longer segments help maintain semantic integrity and reduce misinterpretation. |
Recall count (Recall Count) | Top 10 | Clinical trial pre-screening requires comprehensive coverage of potential exclusion/inclusion criteria. Appropriately increasing the recall count can improve the coverage of relevant information and reduce the risk of missed detections. |
Similarity threshold (Similarity Threshold) | 0.75 | Vaccine clinical data contains numerous synonyms, near-synonyms, and specialized abbreviations. A higher similarity threshold helps precisely match key trial parameters and subject characteristics. |
Rerank result count (Reranked Return Count) | Top 5 | After initial recall, a reranking mechanism further filters the most relevant information for pre-screening logic, improving the accuracy and efficiency of subsequent judgments. |
PARSE_FILE_TIMEOUT_SECONDS | 600 seconds | Attenuated inactivated vaccine clinical trial documents (e.g., PDF investigator brochures) are often large and contain complex diagrams. Parsing can be time-consuming, and extending the timeout helps prevent parsing failures. |
Common Pitfalls
- A high rate of false positives or false negatives in pre-screening results, due to the knowledge base not including the latest vaccine strain information or specific disease subtype codes, leading to critical entity recognition failures.
- Workflow execution timeouts or slowdowns, caused by not effectively chunking or parallel processing large clinical trial protocol documents, resulting in an excessive load on text processing modules.
- The AI conversation fails to correctly cite knowledge base information, instead providing generic answers, because the query construction after the knowledge base node in the workflow is inaccurate, failing to effectively trigger relevant knowledge recall.
Verification Steps
- Select attenuated inactivated vaccine clinical trial protocol documents containing typical exclusion/inclusion criteria, run them through the workflow, and check the output to verify accurate identification of all key screening conditions.
- For a document containing various dosages, treatment durations, and immunogenicity indicators, verify that the workflow can precisely extract and standardize these values with units, comparing them against the original document.
- Simulate submitting specific subject data and observe whether the workflow provides correct inclusion or exclusion recommendations based on the preset screening logic, tracing back to specific clauses cited from the knowledge base.
- Check workflow logs to confirm that when processing complex documents, the execution time of each processing step (e.g., file parsing, entity recognition, knowledge retrieval) is within an acceptable range, with no abnormal timeouts or errors.
The values provided are common starting points and should be measured against the reader's own samples.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.